Benu BioVentures

Benu BioVentures is a new biopharmaceutical investment initiative to fund and develop preclinical stage pharmaceutical investments to the human proof-of-concept stage. Leveraging Benu BioPharma's management expertise in technology commercialization and pharmaceutical development, Benu BioVentures is creating and financing virtual companies that will move candidate drugs toward human proof of concept studies in a cost and time efficient manner. Funding activities will focus on product candidates with strong animal data and a clear regulatory path that address unmet medical needs. Benu BioVentures is led by Dennis Goldberg, Ph.D., FAHA and Fred Meyer, Ph.D., CFA, both recognized biopharmaceutical serial entrepreneurs.